Scapho 150mg Injection belongs to the monoclonal antibody category, containing the active ingredient Secukinumab. It treats moderate to severe plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis. Plaque psoriasis is a skin condition caused by inflammation. This Injection is an interleukin inhibitor that reduces symptoms like itching, scaling, and pain and improves skin clearance. In psoriatic arthritis, Scapho 150mg Injection is either given alone or with Methotrexate to improve the bone and cartilage of the joints and improve your ability to do regular physical activity. In axial spondyloarthritis, this medicine reduces the signs and symptoms and enhances physical function.

Contact your healthcare provider right away if you develop any symptoms of infection while on treatment with this drug. It is not recommended if you are allergic to latex, Scapho 150mg Injection or any of its ingredients or have a history of tuberculosis. Tell your healthcare provider if you have been diagnosed with heart problems, nervous system disorders, ulcerative colitis, or Crohn’s disease. During this treatment your physician may monitor your vitals to prevent serious complications. Inform your health care provider if you are about to undergo any dental or surgical procedures. Seek immediate medical attention if you notice dark urine, yellowing of skin, red, scaly patches on skin, unusual bruising, breathing trouble, hives, or chest pain.

Ask your health care provider for advice if you are pregnant, think you might be pregnant, are planning to have a baby, or are breastfeeding your baby. Scapho 150mg Injection is probably unsafe during pregnancy. Tell your doctor before you breastfeed your baby. Your doctor will decide whether you should receive this injection or breastfeed depending on your condition. Discuss effective contraceptive methods with your healthcare provider and consider using them for at least 20 weeks after the last dose of this drug.

Moderate to severe plaque psoriasis.

Active Psoriatic arthritis.

Active Ankylosing spondylitis.

Axial spondyloarthritis.

Non-Radiographic axial spondyloarthritis.

Scapho 150mg Injection specifically targets and inhibits the activity of a protein called interleukin-17A (IL-17A), which plays an important role in the body's immune response. By blocking IL-17A, this drug helps to reduce inflammation and manage symptoms of psoriasis, hidradenitis suppurativa, psoriatic arthritis, and axial spondyloarthritis. 

Scapho 150mg Injection will be given as a subcutaneous (under the skin) injection, usually once daily. The injection should be given at the same time every day, preferably in the morning. Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity and other factors. 

Infections

Inflammatory bowel disease is characterized by symptoms of diarrhea, stomach pain, and blood in stool.

Hypersensitivity reactions with symptoms of skin rash, dizziness, breathlessness, chest tightness, and swelling of the face, eyelids, lips, mouth, tongue, or throat.

Upper Respiratory infections

Cold symptoms

Diarrhea

Runny nose

Headache

Nausea

Tiredness

Inform your physician about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Scapho 150mg Injection and reduce effectiveness by causing undesirable side effects.

Store Scapho 150mg Injection in a refrigerator (2-8°C).

Keep out of reach of children.

Check with your health care provider before receiving any vaccines and inform them if you are taking any other medications or herbal supplements.